Cardiovascular Diseases

At Diabetespraxis Dr. Braun in Berlin, cardiovascular research focuses on preventing major events in people with atherosclerotic cardiovascular disease, elevated lipoprotein(a), and high cardiometabolic risk. These studies are designed to test new treatment options and better understand how to reduce heart attack, stroke, and cardiovascular death.

  • Preventing major adverse cardiovascular events in people with established ASCVD
  • Evaluating therapies for first-event prevention in patients with elevated lipoprotein(a)
  • Studying approaches to lower the risk of heart failure and cardiovascular death

Overall, this area combines treatment evaluation with risk reduction strategies for patients facing serious heart and blood vessel complications.

Nutritional and Metabolic Diseases

Much of the clinical trial activity at this site centers on type 2 diabetes, obesity, and overweight. The research is aimed at improving blood sugar control, supporting weight management, and assessing whether newer therapies can offer better outcomes than current standard care.

  • Testing new options for type 2 diabetes mellitus with increased cardiovascular risk
  • Studying treatments for chronic weight management in adults with obesity or overweight
  • Exploring therapies that may improve both metabolic health and cardiovascular outcomes

These trials reflect a strong focus on practical, patient-centered care for common metabolic conditions.

Metabolism

Research in metabolism at Diabetespraxis Dr. Braun includes studies of how the body regulates glucose, body weight, and related metabolic pathways. The main goal is to identify therapies that can improve long-term disease control while also addressing broader health risks linked to diabetes and excess weight.

  • Assessing agents that may support better glycemic control
  • Investigating treatments that influence body weight and metabolic balance
  • Examining links between metabolism and cardiovascular protection

This makes the site relevant for research that bridges diabetes care, weight management, and prevention of complications.

Nervous System Diseases

The site also contributes to research on nervous system diseases, especially diabetic peripheral neuropathic pain. These trials are focused on finding better ways to relieve chronic nerve pain and improve quality of life for people living with diabetes-related complications.

  • Evaluating pain relief options for diabetic peripheral neuropathic pain
  • Studying new approaches to symptom control in diabetes-related nerve disease
  • Exploring treatments that may improve day-to-day comfort and function

This research area adds an important complication-focused dimension to the site’s broader diabetes portfolio.

Kidney and Cardio-Metabolic Complications

Several trials at the site examine complications that connect chronic kidney disease, hypertension, diabetes, and cardiovascular risk. The purpose is to test whether new therapies can slow disease progression and reduce the chance of serious kidney or heart-related outcomes.

  • Studying ways to slow progression of chronic kidney disease
  • Evaluating treatment strategies for patients with CKD and hypertension
  • Assessing whether combined metabolic and blood pressure management can improve outcomes

These studies highlight the interconnected nature of kidney, metabolic, and cardiovascular health in diabetes care.

Type 1 Diabetes Research

In addition to type 2 diabetes studies, the site is involved in research on type 1 diabetes mellitus, including recently diagnosed adolescents and adults. The main aim is to explore whether new therapies can help preserve insulin production and improve overall glucose management.

  • Investigating preservation of beta cell function in newly diagnosed type 1 diabetes
  • Assessing whether treatment can support better glycemic control
  • Studying approaches intended to help maintain natural insulin secretion

This work supports earlier intervention strategies in autoimmune diabetes and complements the site’s broader metabolic research.

Clinical Trial Delivery and Participant Experience

Beyond disease-specific studies, Diabetespraxis Dr. Braun is also involved in research on how clinical trials are conducted. These studies look at whether more flexible, participant-centered trial models can improve recruitment, retention, satisfaction, and data quality in people with diabetes.

  • Comparing decentralized and hybrid trial approaches with standard site-based research
  • Assessing participant convenience, safety oversight, and treatment adherence
  • Exploring ways to make trials more accessible and efficient

This area reflects interest in improving not only treatments, but also how research is delivered to patients.